183 related articles for article (PubMed ID: 12437499)
1. Acyl coenzyme A:cholesterol acyltransferase inhibition: potential atherosclerosis therapy or springboard for other discoveries?
Heinonen TM
Expert Opin Investig Drugs; 2002 Nov; 11(11):1519-27. PubMed ID: 12437499
[TBL] [Abstract][Full Text] [Related]
2. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
3. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
Leon C; Hill JS; Wasan KM
Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
[TBL] [Abstract][Full Text] [Related]
4. Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.
Chang C; Dong R; Miyazaki A; Sakashita N; Zhang Y; Liu J; Guo M; Li BL; Chang TY
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):151-6. PubMed ID: 16518538
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.
Miyazaki A; Kanome T; Watanabe T
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):463-9. PubMed ID: 16503866
[TBL] [Abstract][Full Text] [Related]
7. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.
Ikenoya M; Yoshinaka Y; Kobayashi H; Kawamine K; Shibuya K; Sato F; Sawanobori K; Watanabe T; Miyazaki A
Atherosclerosis; 2007 Apr; 191(2):290-7. PubMed ID: 16820149
[TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acyl coenzyme A-cholesterol acyltransferase: a possible treatment of atherosclerosis?
Heinonen TM
Curr Atheroscler Rep; 2002 Jan; 4(1):65-70. PubMed ID: 11772425
[TBL] [Abstract][Full Text] [Related]
10. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of acyl-CoA:cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis.
Tauchi Y; Yoshimi A; Shirahase H; Sato J; Ito K; Morimoto K
Biol Pharm Bull; 2003 Jan; 26(1):73-8. PubMed ID: 12520177
[TBL] [Abstract][Full Text] [Related]
14. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
Burnett JR; Wilcox LJ; Huff MW
Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of acyl coenzyme A:cholesterol acyltransferase blocks esterification but not uptake of cholesterol in Caco-2 cells.
Ellsworth JL; Starr JR
Metabolism; 1998 Mar; 47(3):325-32. PubMed ID: 9500571
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
[TBL] [Abstract][Full Text] [Related]
17. Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs.
Alegret M; Llaverias G; Silvestre JS
Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):563-86. PubMed ID: 15538545
[TBL] [Abstract][Full Text] [Related]
18. N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]- (2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme a:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice.
Nagata Y; Yonemoto M; Iwasawa Y; Shimizu-Nagumo A; Hattori H; Sawazaki Y; Kamei T
Biochem Pharmacol; 1995 Mar; 49(5):643-51. PubMed ID: 7887979
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
20. Heterocyclic amides: inhibitors of acyl-CoA:cholesterol O-acyl transferase with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit.
White AD; Purchase CF; Picard JA; Anderson MK; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Krause BR; Lee P; Stanfield RL; Reindel JF
J Med Chem; 1996 Sep; 39(20):3908-19. PubMed ID: 8831757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
